Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19

Michael G. Ison^*, Marc H. Scheetz

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

17 Scopus citations

ASJC Scopus subject areas

@article{48f821f4add945c297e988b17f15a983,

title = "Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19",

author = "Ison, {Michael G.} and Scheetz, {Marc H.}",

year = "2021",

month = jan,

doi = "10.1016/j.ebiom.2020.103204",

language = "English (US)",

volume = "63",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Understanding the pharmacokinetics of Favipiravir

T2 - Implications for treatment of influenza and COVID-19

AU - Ison, Michael G.

AU - Scheetz, Marc H.

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85098945975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098945975&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2020.103204

DO - 10.1016/j.ebiom.2020.103204

M3 - Comment/debate

C2 - 33418497

AN - SCOPUS:85098945975

SN - 2352-3964

VL - 63

JO - EBioMedicine

JF - EBioMedicine

M1 - 103204

ER -